Explore our core selection of high-purity natural compounds and chemical intermediates manufactured under strict global standards.
Chengdu ChenLv Herb Co.,Ltd. (referred to as "Chenlv Herb") was established in 2012 as a high-tech enterprise specializing in the R&D, production, and sales of botanical extracts and natural pharmaceutical ingredients. Committed to providing high-purity, highly active, and premium-quality natural raw materials, the company serves diverse industries, including pharmaceuticals, health supplements, food, and cosmetics.
Established In
In modern preventative cardiology and clinical biochemistry, measuring low-density lipoprotein cholesterol (LDL-C) with absolute precision is paramount. Clinical laboratories worldwide rely on direct LDL assay reagents to bypass the inaccuracies inherent in traditional calculation methods like the Friedewald formula. As a leading manufacturer, Chengdu Chenlv Herb Co., Ltd. sits at the intersection of biochemical diagnostic formulation and botanical active pharmaceutical ingredients (APIs). Our high-grade natural surfactants, bile acid derivatives, and therapeutic extracts supply the critical infrastructure needed for diagnostic accuracy and metabolic wellness.
In clinical chemistry, LDL Direct refers to homogenous enzymatic assays that directly isolate and quantify LDL-C. "High" denotes both the high-accuracy demand of diagnostic kit manufacturers and the therapeutic targeting of high serum LDL levels using advanced natural modulators like Dihydroberberine, Magnolol, and Naringin.
In homogenous assays for LDL-C, specific surfactants and bile salts—such as Taurodeoxycholate Sodium and Dehydrocholic Acid—are used to selectively solubilize and block non-LDL lipoproteins (such as chylomicrons, VLDL, and HDL). If the purity of these bile salts fluctuates even slightly, the enzyme reaction (cholesterol esterase and oxidase) will cross-react with other lipid fractions. This leads to erroneous diagnostic profiles, impacting patient treatments. Sourcing direct from a verified cGMP manufacturer ensures:
Choose Chenlv Herb for products that deliver beyond expectations
Creative designs and proprietary extraction processes that elevate your brand and therapeutic efficacy.
Eco-friendly packaging and optimized manufacturing processes aligned with modern environmental standards.
End-to-end sustainable sourcing and green organic solvent recovery in all botanical extractions.
Fast turnaround, comprehensive logistics coordination, and direct technical support to meet your strict timelines.
A dedicated QA/QC team supporting you with analytical testing, HPLC profiles, and certificate verification every step of the way.
Over a decade of core botanical and chemical synthesis expertise ensuring precision, safety, and operational excellence.
Chengdu, situated in the Sichuan province of China, is globally recognized as a premier bio-resource hub. Known as the "natural treasure house of medicine," this region provides a rich source of raw botanicals. By operating our factory in Chengdu, Chenlv Herb secures unique advantages for international procurement teams:
The global demand for natural active compounds targeting cholesterol, LDL, and metabolic health is expanding rapidly. The push for plant-derived alternatives to synthetic statins has positioned compounds like Dihydroberberine and Apigenin at the forefront of natural health product (NHP) development. Scientific validation of these compounds continues to grow:
Dihydroberberine, for instance, shows significantly higher bioavailability than standard Berberine HCl, requiring a lower dose to achieve comparable AMPK activation and direct LDL receptor expression optimization. Similarly, Magnolol modulates PPAR-gamma receptors to assist in lipid clearance. International formulation brands are shifting away from generic multivitamins toward these highly targeted metabolic activators to differentiate their brand and secure "information gain" in consumer health education.
Our premium compounds serve critical functions across diverse industries, from precision clinical assays to nutritional health.
Driven by the concept of "homology of medicine and food" and modern health needs, plant extracts have gradually become the core raw materials for the development of health care products due to their natural, green and safe characteristics.
READ MORE
From herbal formulas recorded in ancient books to modern innovative drugs, plant extracts occupy the prominent position in the pharmaceutical industry due to their natural active ingredients and unique pharmacological effects.
READ MORE
With consumers' pursuit of natural, safe, and sustainable skincare concepts, plant extracts have become a new favorite in the cosmetics industry due to their mildness, versatility, and biocompatibility, bringing new solutions for skin care.
READ MORE
Plant extracts have shown great potential in improving animal health, enhancing production performance and optimizing culture benefits, and are gradually becoming a research hotspot and new favorite in the field of animal nutrition.
READ MORE
B2B procurement agents face a major challenge: batch-to-batch variation in bioactive potency. A botanical source harvested during a rainy season may yield up to 40% less active chemical compounds than one harvested in dry months. At Chenlv Herb, we mitigate this systemic challenge using advanced standardization protocols:
Chenlv Herb provides one-stop contract manufacturing and supply chain services.
Communicate directly with customers to determine product specifications, grade, and application requirements.
Provide a detailed commercial proposal and pricing structure based on scale and target purity specifications.
Sign a comprehensive supply contract, detailing quality criteria, lead times, and regulatory support agreements.
Formulate laboratory-scale samples for customer analysis, verification, and clinical application approval.
Upon sample sign-off, our GMP-compliant factory schedules commercial scale production to meet requirements.
Perform strict quality verification on finished batches, issuing certified Certificates of Analysis (CoA).
Pack under inert gas protection where needed and deliver finished goods to domestic or international destinations.
Our company's production facilities and products are certified by ISO9001, ISO22000, HALAL, KOSHER, FDA, and more.
Essential insights for raw materials procurement managers, R&D formulation scientists, and quality managers.
They act as selective detergent blocks. In clinical LDL Direct reagents, these specific bile acids solubilize chylomicrons, VLDL, and HDL selectively so they can react with introductory enzymes, while LDL-C remains shielded until the secondary phase of the reaction, ensuring high accuracy.
We source active botanicals from dedicated agricultural cooperatives with strict GAP controls. In our facility, we standardize processing parameters (temperature, pressure, solvent ratio) and analyze each batch via HPLC, comparing chromatograms against standard references.
Yes. We offer custom milling and micronization services, adjusting particle size distributions down to D90 < 10 microns, optimizing dispersion and dissolution rates for clinical therapeutic formulations.
Every single batch undergoes ICP-MS testing for heavy metals (Lead, Cadmium, Arsenic, Mercury) and GC-MS/MS for pesticide residues. We strictly comply with EP 2.8.13 and USP <561> limits, providing complete reports with every shipment.
We provide comprehensive technical documentation packages including Certificates of Analysis (CoA), Safety Data Sheets (SDS), process flow diagrams, BSE/TSE-free certificates, GMO declarations, and Kosher/Halal certification documents.
For standard stocked ingredients, shipment from our factory is initiated within 3-5 working days. For custom syntheses or specific botanical crops, lead times vary between 2-4 weeks, subject to scale and refinement requirements.
Stay up to date with key market dynamics, botanical crop price trends, and upcoming global industry events.
Recently, the market price of Citrus aurantium raw materials in China has been on the rise, drawing significant attention from the industry. As the new production season (May-June) comes to an end and new supplies gradually enter the market, price fluctuations have become a focal point due to supply and demand dynamics and cost considerations.
As a 'calling card' for leading China's pharmaceutical industry onto the global stage, the 23rd China Pharmaceutical Raw Materials Exhibition (CPHI China 2025) will join hands with the 18th China Pharmaceutical Machinery to foster new growth opportunities.
Discover our latest innovations in high-purity bile acids and bio-active botanical extraction technologies. Join our technical engineers at the API conference to discuss custom synthesis and formulation projects.
Exhaustive list of high-grade raw ingredients manufactured in our state-of-the-art facility.